Denosumab 60mg: increased risk of multiple vertebral fractures after stopping or delaying ongoing treatment
A patient’s individual factors for benefits and risks should be evaluted before initiating treatment with denosumab 60mg, particularly in those with previous vertebral fracture.
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via